South Africa Self-monitoring Blood Glucose Devices Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

The South Africa Self-Monitoring Blood Glucose Devices Market is Segmented by Components (Glucometer Devices, Test Strips, and Lancets). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

South Africa Self-monitoring Blood Glucose Devices Market Size and Share

South Africa Self-monitoring Blood Glucose Devices Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

South Africa Self-monitoring Blood Glucose Devices Market Analysis by Mordor Intelligence

The South Africa Self-monitoring Blood Glucose Devices Market size was valued at USD 22.93 million in 2026 and is estimated to grow from USD 23.39 million in 2027 to reach USD 25.84 million by 2032, at a CAGR of 2.01% during the forecast period (2027-2032).

Patients with diabetes infected with COVID-19 experienced elevated blood glucose, abnormal glucose variability, and diabetic complications. The Western Cape Provincial Health Department's data on COVID-19 fatalities suggested that people with diabetes were more likely to die from COVID-19 than any other high-risk group. The provincial health department estimated that out of every 100 people within the public healthcare sector who died from COVID-19, 52 had diabetes. While new-onset hyperglycemia and new-onset diabetes were increasingly recognized in the context of COVID-19 and were associated with worse outcomes. To avoid aggravation, a patient's blood glucose should be monitored and maintained regularly, which has underlined the importance of diabetes care devices.

According to IDF Diabetes Atlas 2021, one in nine adults in South Africa were living with diabetes. The main diagnosis for diabetes patients was imbalances in blood glucose levels, which are not in compliance with the standard blood glucose levels. The general lab diagnostic tests can only help to diagnose the disease by physicians. Patients with more fluctuations in glucose levels need to get it checked every day. Patients taking insulin need to check their blood glucose levels frequently, adjust the doses of insulin, or change the medication if necessary.

The rate of newly diagnosed type 1 and type 2 diabetes cases is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure in developed countries are indications of the increasing usage of diabetic care products. Self-blood glucose monitoring allows a patient to check their blood glucose levels as often as they need to or as recommended. Over time, the readings provide the patient and their health professionals with the information required to determine the best management strategy for diabetes. Leading manufacturers are focusing on technological innovations and the development of advanced products to gain a substantial share of the market.

Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.

Competitive Landscape

The South Africa self-monitoring blood glucose devices market is moderately fragmented, with few significant and other generic players. Manufacturers like Abbott, F. Hoffmann-La Roche AG, Ascensia, etc. occupy a major share.

South Africa Self-monitoring Blood Glucose Devices Industry Leaders

  1. Roche

  2. Ascensia

  3. Abbott

  4. Lifescan

  5. Arkray

  6. *Disclaimer: Major Players sorted in no particular order
South Africa Self-monitoring Blood Glucose Devices Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Recent Industry Developments

  • January 2023: LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology published Improved Glycemic Control Using a Bluetooth Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence from Over 144,000 People with Diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes - one of the largest combined blood glucose meter and mobile diabetes app datasets ever published.
  • June 2022: LifeScan announced that the peer-reviewed journal Diabetes Technology and Therapeutics (DTT) had published real-world evidence of improved glycemic control in people with diabetes using a Bluetooth-connected blood glucose meter with Mobile Diabetes Management Application using the OneTouch Reveal mobile app with the OneTouch Verio Reflect meter- synced via Bluetooth wireless technology. This could support improved glycemic control for people with diabetes.

Table of Contents for South Africa Self-monitoring Blood Glucose Devices Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Glucometer Devices
  • 5.2 Test Strips
  • 5.3 Lancets

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Holding AG
    • 7.1.3 LifeScan
    • 7.1.4 Trividia Health
    • 7.1.5 Ascensia Diabetes Care
    • 7.1.6 Acon Laboratories Inc.
    • 7.1.7 Agamatrix Inc.
    • 7.1.8 Bionime Corporation
    • 7.1.9 Sinocare
    • 7.1.10 Arkray Inc.
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Abbott Diabetes Care
    • 7.2.2 Roche Holding AG
    • 7.2.3 Others

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

South Africa Self-monitoring Blood Glucose Devices Market Report Scope

Self-monitoring of blood glucose is an approach used by diabetic patients to measure their blood glucose level themselves, using a glucometer, test strips, and lancets. Based on the readings, patients can adjust or check the effect of their treatment. The South Africa self-monitoring blood glucose devices market is segmented into components (glucometer devices, test strips, lancets). The report offers the value (in USD) and volume (in Units) for the above segments.

South Africa Self-monitoring Blood Glucose Devices Market segmentation breakdown

Key Questions Answered in the Report

How big is the South Africa Self-monitoring Blood Glucose Devices Market?

The South Africa Self-monitoring Blood Glucose Devices Market size is expected to reach USD 23.39 million in 2027 and grow at a CAGR of 2.01% to reach USD 25.84 million by 2032.

What is the current South Africa Self-monitoring Blood Glucose Devices Market size?

In 2026, the South Africa Self-monitoring Blood Glucose Devices Market size is expected to reach USD 22.93 million.

Who are the key players in South Africa Self-monitoring Blood Glucose Devices Market?

Roche, Ascensia, Abbott, Lifescan and Arkray are the major companies operating in the South Africa Self-monitoring Blood Glucose Devices Market.

What years does this South Africa Self-monitoring Blood Glucose Devices Market cover, and what was the market size in 2025?

In 2025, the South Africa Self-monitoring Blood Glucose Devices Market size was estimated at USD 22.48 million. The report covers the South Africa Self-monitoring Blood Glucose Devices Market historical market size for years: 2021, 2022, 2023, 2024, and 2025. The report also forecasts the South Africa Self-monitoring Blood Glucose Devices Market size for years: 2027, 2028, 2029, 2030, 2031, and 2032.

Page last updated on:

South Africa Self-monitoring Blood Glucose Devices Market Report Snapshots